- \n\t\t\t\t\t\t\t
- \n\t\t\t\t\t\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\tHome<\/span>\n\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t
- \n\t\t\t\t\t\t\t\t\t\tProducts<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t
- \n\t\t\t\t\t\t\t\t\t\tSoftware<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t
- \n\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\tSaaS Software<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t \n\t\t\t\t\t\n\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\n\t\t\t\t\tLDAf\u2122
\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\n\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\n\t\t\t\t\tPatented Parametric Response Mapping (PRM) technology\n<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\n\n\n\n\n\nLDAf\u2122 (Functional Lung Density Analysis) is the only fully-automated image analysis tool providing a complete mapping of normal lung, air-trapping, and areas indicative of emphysema in a combined image to visualize and quantify the components of COPD. LDAf can be useful in assessing other density-evident conditions including BOS, Asthma, and combination diseases as well.<\/p>\n
FDA 510(k) Cleared, ARTGApproved, CE Mark Certified, Health Canada Approved<\/em><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t \n\t\t\t\t\t\n\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\n\t\t\t\t\tThe Power of Personalized Quantitative Imaging<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\t\t\t\t\tLDAf offers advanced density analysis for patients with COPD, Asthma, Bronchiolitis Obliterans Syndrome, and other conditions. LDAf provides maximum information for personalized care decisions as well as surgical and interventional procedure planning.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\t\t\t\n\t\t\t\n\t\t\t\t\t\t\t\t![\"Differentiate](\"https:\/\/4dmedical.com\/us\/wp-content\/uploads\/sites\/2\/2025\/05\/Lung-Function-Imaging-Assessments.jpg\")
Differentiate Your Patients and Customize Their Treatments<\/h6>\nHere are four patients with the same standard clinical assessments. LDAf provides data\nto:\n1. Determine what specific lung regions are affected. 2. Assess how diffuse\n(homogenous) or concentrated (heterogeneous) is the disease. 3. Phenotype just how\nmuch potential full\n-\nfledged emphysema there is vs. air\n-\ntrapping.\n<\/figcaption><\/figure><\/a><\/div>
- \n\t\t\t\t\t\t\t\t\t\tProducts<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t
![\"LDAf-Functional-Report-5.0.png\"](\"https:\/\/4dmedical.com\/us\/wp-content\/uploads\/sites\/2\/2025\/05\/LDAf-Functional-Report-5.0.png\")
![\"Automated](\"https:\/\/4dmedical.com\/us\/wp-content\/uploads\/sites\/2\/2025\/05\/Lenny-Doe_LDAf_axial-side-by-side-scaled-1-768x435.jpg\")